1
|
Saxena A, Majee S, Ray D, Saha B. Inhibition of cancer cells by Quinoline-Based compounds: A review with mechanistic insights. Bioorg Med Chem 2024; 103:117681. [PMID: 38492541 DOI: 10.1016/j.bmc.2024.117681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2024] [Revised: 03/11/2024] [Accepted: 03/11/2024] [Indexed: 03/18/2024]
Abstract
This article includes a thorough examination of the inhibitory potential of quinoline-based drugs on cancer cells, as well as an explanation of their modes of action. Quinoline derivatives, due to their various chemical structures and biological activity, have emerged as interesting candidates in the search for new anticancer drugs. The review paper delves into the numerous effects of quinoline-based chemicals in cancer progression, including apoptosis induction, cell cycle modification, and interference with tumor-growth signaling pathways. Mechanistic insights on quinoline derivative interactions with biological targets enlightens their therapeutic potential. However, obstacles such as poor bioavailability, possible off-target effects, and resistance mechanisms make it difficult to get these molecules from benchside to bedside. Addressing these difficulties might be critical for realizing the full therapeutic potential of quinoline-based drugs in cancer treatment.
Collapse
Affiliation(s)
- Anjali Saxena
- Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh
| | - Suman Majee
- Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh; Amity Institute of Click Chemistry Research and Studies, Amity University, Noida, Uttar Pradesh
| | - Devalina Ray
- Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh; Amity Institute of Click Chemistry Research and Studies, Amity University, Noida, Uttar Pradesh
| | - Biswajit Saha
- Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh.
| |
Collapse
|
2
|
Majee S, Sarav M, Banik BK, Ray D. Recent Advances in the Green Synthesis of Active N-Heterocycles and Their Biological Activities. Pharmaceuticals (Basel) 2023; 16:873. [PMID: 37375820 DOI: 10.3390/ph16060873] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 06/06/2023] [Accepted: 06/09/2023] [Indexed: 06/29/2023] Open
Abstract
N-heterocyclic scaffolds represent a privileged architecture in the process of drug design and development. It has widespread occurrence in synthetic and natural products, either those that are established or progressing as potent drug candidates. Additionally, numerous novel N-heterocyclic analogues with remarkable physiological significance and extended pharmaceutical applications are escalating progressively. Hence, the classical synthetic protocols need to be improvised according to modern requirements for efficient and eco-friendly approaches. Numerous methodologies and technologies emerged to address the green and sustainable production of various pharmaceutically and medicinally important N-heterocyclic compounds in last few years. In this context, the current review unveils greener alternatives for direct access to categorically differentiated N-heterocyclic derivatives and its application in the establishment of biologically active potent molecules for drug design. The green and sustainable methods accentuated in this review includes microwave-assisted reactions, solvent-free approaches, heterogeneous catalysis, ultrasound reactions, and biocatalysis.
Collapse
Affiliation(s)
- Suman Majee
- Amity Institute of Click Chemistry Research and Studies, Amity University, Sector 125, Noida 201313, Uttar Pradesh, India
- Amity Institute of Biotechnology, Amity University, Sector 125, Noida 201313, Uttar Pradesh, India
| | - Mansi Sarav
- Amity Institute of Biotechnology, Amity University, Sector 125, Noida 201313, Uttar Pradesh, India
| | - Bimal Krishna Banik
- Department of Mathematics and Natural Sciences, College of Sciences and Human Studies, Prince Mohammad Bin Fahd University, Al Khobar 31952, Saudi Arabia
| | - Devalina Ray
- Amity Institute of Click Chemistry Research and Studies, Amity University, Sector 125, Noida 201313, Uttar Pradesh, India
- Amity Institute of Biotechnology, Amity University, Sector 125, Noida 201313, Uttar Pradesh, India
| |
Collapse
|
3
|
Weiss S, Waidha K, Rajendran S, Benharroch D, Khalilia J, Levy H, Bar-David E, Golan-Goldhirsh A, Gopas J, Ben-Shmuel A. In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from Nuphar lutea on Cells and K18- hACE2 Mice Infected with SARS-CoV-2. Int J Mol Sci 2023; 24:ijms24098327. [PMID: 37176034 PMCID: PMC10179516 DOI: 10.3390/ijms24098327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 04/27/2023] [Accepted: 05/02/2023] [Indexed: 05/15/2023] Open
Abstract
We have previously published research on the anti-viral properties of an alkaloid mixture extracted from Nuphar lutea, the major components of the partially purified mixture found by NMR analysis. These are mostly dimeric sesquiterpene thioalkaloids called thiobinupharidines and thiobinuphlutidines against the negative strand RNA measles virus (MV). We have previously reported that this extract inhibits the MV as well as its ability to downregulate several MV proteins in persistently MV-infected cells, especially the P (phospho)-protein. Based on our observation that the Nuphar extract is effective in vitro against the MV, and the immediate need that the coronavirus disease 2019 (COVID-19) pandemic created, we tested here the ability of 6,6'-dihydroxythiobinupharidine DTBN, an active small molecule, isolated from the Nuphar lutea extract, on COVID-19. As shown here, DTBN effectively inhibits SARS-CoV-2 production in Vero E6 cells at non-cytotoxic concentrations. The short-term daily administration of DTBN to infected mice delayed the occurrence of severe clinical outcomes, lowered virus levels in the lungs and improved survival with minimal changes in lung histology. The viral load on lungs was significantly reduced in the treated mice. DTBN is a pleiotropic small molecule with multiple targets. Its anti-inflammatory properties affect a variety of pathogens including SARS-CoV-2 as shown here. Its activity appears to target both pathogen specific (as suggested by docking analysis) as well as cellular proteins, such as NF-κB, PKCs, cathepsins and topoisomerase 2, that we have previously identified in our work. Thus, this combined double action of virus inhibition and anti-inflammatory activity may enhance the overall effectivity of DTBN. The promising results from this proof-of-concept in vitro and in vivo preclinical study should encourage future studies to optimize the use of DTBN and/or its molecular derivatives against this and other related viruses.
Collapse
Affiliation(s)
- Shay Weiss
- Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 7410001, Israel
| | - Kamran Waidha
- The Shraga Segal Department of Microbiology, Immunology & Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel
| | - Saravanakumar Rajendran
- Chemistry Division, SAS, Vellore Institute of Technology, Chennai Campus, Chennai 600127, India
| | - Daniel Benharroch
- Department of Pathology, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel
| | - Jannat Khalilia
- The Shraga Segal Department of Microbiology, Immunology & Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel
| | - Haim Levy
- Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 7410001, Israel
| | - Elad Bar-David
- Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 7410001, Israel
| | - Avi Golan-Goldhirsh
- The Jacob Blaustein Institutes for Desert Research (BIDR), Ben-Gurion University of the Negev, Sede Boqer Campus, Sde Boker 8410501, Israel
| | - Jacob Gopas
- The Shraga Segal Department of Microbiology, Immunology & Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel
| | - Amir Ben-Shmuel
- Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 7410001, Israel
| |
Collapse
|
4
|
Ang D, Kendall R, Atamian HS. Virtual and In Vitro Screening of Natural Products Identifies Indole and Benzene Derivatives as Inhibitors of SARS-CoV-2 Main Protease (M pro). BIOLOGY 2023; 12:biology12040519. [PMID: 37106720 PMCID: PMC10135783 DOI: 10.3390/biology12040519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Revised: 03/25/2023] [Accepted: 03/26/2023] [Indexed: 04/29/2023]
Abstract
The rapid spread of the coronavirus disease 2019 (COVID-19) resulted in serious health, social, and economic consequences. While the development of effective vaccines substantially reduced the severity of symptoms and the associated deaths, we still urgently need effective drugs to further reduce the number of casualties associated with SARS-CoV-2 infections. Machine learning methods both improved and sped up all the different stages of the drug discovery processes by performing complex analyses with enormous datasets. Natural products (NPs) have been used for treating diseases and infections for thousands of years and represent a valuable resource for drug discovery when combined with the current computation advancements. Here, a dataset of 406,747 unique NPs was screened against the SARS-CoV-2 main protease (Mpro) crystal structure (6lu7) using a combination of ligand- and structural-based virtual screening. Based on 1) the predicted binding affinities of the NPs to the Mpro, 2) the types and number of interactions with the Mpro amino acids that are critical for its function, and 3) the desirable pharmacokinetic properties of the NPs, we identified the top 20 candidates that could potentially inhibit the Mpro protease function. A total of 7 of the 20 top candidates were subjected to in vitro protease inhibition assay and 4 of them (4/7; 57%), including two beta carbolines, one N-alkyl indole, and one Benzoic acid ester, had significant inhibitory activity against Mpro protease. These four NPs could be developed further for the treatment of COVID-19 symptoms.
Collapse
Affiliation(s)
- Dony Ang
- Computational and Data Sciences Program, Chapman University, Orange, CA 92866, USA
- Schmid College of Science and Technology, Chapman University, Orange, CA 92866, USA
| | - Riley Kendall
- Computational and Data Sciences Program, Chapman University, Orange, CA 92866, USA
- Schmid College of Science and Technology, Chapman University, Orange, CA 92866, USA
| | - Hagop S Atamian
- Schmid College of Science and Technology, Chapman University, Orange, CA 92866, USA
- Biological Sciences Program, Chapman University, Orange, CA 92866, USA
| |
Collapse
|
5
|
Kushwaha P, Kumar V, Saha B. Current development of β-carboline derived potential antimalarial scaffolds. Eur J Med Chem 2023; 252:115247. [PMID: 36931118 DOI: 10.1016/j.ejmech.2023.115247] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2022] [Revised: 02/26/2023] [Accepted: 03/01/2023] [Indexed: 03/12/2023]
Abstract
β-Carboline alkaloids are an eminent class of nitrogen-based natural alkaloids and therapeutic molecules which exert various pharmacological activities through diverse mechanisms. A lot of attention has recently been directed towards this moiety in order to develop effective antimalarial drugs. "Malaria", an acute febrile illness caused by diverse Plasmodium parasites, is a continuing and escalating problem that devastates economically less developed countries by significantly increased morbidity and mortality rates. The mounting parasite resistance towards the antimalarial drugs and augmenting the 'habitat of the insect vector' are creating a catastrophe, indicating an urgent need for new efficacious therapeutics to combat this tropical disease. This article comprehensively encapsulates the clinical and preclinical antimalarial scaffolds comprising β-carboline moiety in their structure. Herein, various classes of natural and semi-synthetic analogues of β-carbolines reported in the last decade (2011-2021) have been extensively studied and illustrated. This review will help the readers to develop an insight into the β-carboline based antimalarials and molecular mechanisms lying behind their mode of action, which is anticipated to be beneficial for the future development of new β-carboline based therapeutics.
Collapse
Affiliation(s)
- Preeti Kushwaha
- Amity Institute of Biotechnology, Amity University, Sector 125, Noida, 201303, Uttar Pradesh, India
| | - Vipin Kumar
- Sophisticated Analytical Instrument Facility and Research Division, CSIR-Central Drug Research Institute, Lucknow, 226031, Uttar Pradesh, India
| | - Biswajit Saha
- Amity Institute of Biotechnology, Amity University, Sector 125, Noida, 201303, Uttar Pradesh, India.
| |
Collapse
|
6
|
Singh M, Jamra R, Mehra S, Rattan S, Singh V. Potassium
Tert
‐Butoxide‐Promoted Synthesis of Fluorescent β‐Carboline Tethered 1,3,5‐Triazines and Assessment of Their Luminescent Properties. ASIAN J ORG CHEM 2021. [DOI: 10.1002/ajoc.202100281] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- Manpreet Singh
- Department of Chemistry Dr B. R. Ambedkar National Institute of Technology (NIT) Jalandhar Punjab 144011 India
| | - Rahul Jamra
- Department of Chemistry Dr B. R. Ambedkar National Institute of Technology (NIT) Jalandhar Punjab 144011 India
- Department of Chemistry Central University of Punjab Bathinda Punjab 151401 India
| | - Saloni Mehra
- Amity Institute of Applied Sciences Amity University Noida 201313 India
| | - Sunita Rattan
- Amity Institute of Applied Sciences Amity University Noida 201313 India
| | - Virender Singh
- Department of Chemistry Dr B. R. Ambedkar National Institute of Technology (NIT) Jalandhar Punjab 144011 India
- Department of Chemistry Central University of Punjab Bathinda Punjab 151401 India
| |
Collapse
|
7
|
Kumar V, Sachdeva C, Waidha K, Sharma S, Ray D, Kumar Kaushik N, Saha B. In Vitro and In Silico Anti‐plasmodial Evaluation of Newly Synthesized β‐Carboline Derivatives. ChemistrySelect 2021. [DOI: 10.1002/slct.202101355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Vipin Kumar
- Amity Institute of Click Chemistry Research and Studies Amity University Sector 125 Noida 201313, Uttar Pradesh India
| | - Cheryl Sachdeva
- Amity Institute of Virology and Immunology Institution Amity University Sector 125 Noida 201313, Uttar Pradesh India
| | - Kamran Waidha
- Amity Institute of Biotechnology Amity University Sector 125 Noida 201313, Uttar Pradesh India
| | - Sunil Sharma
- Chemical Engineering Department National Tsing Hua University Hsinchu Taiwan 30013
| | - Devalina Ray
- Amity Institute of Biotechnology Amity University Sector 125 Noida 201313, Uttar Pradesh India
| | - Naveen Kumar Kaushik
- Amity Institute of Virology and Immunology Institution Amity University Sector 125 Noida 201313, Uttar Pradesh India
| | - Biswajit Saha
- Amity Institute of Biotechnology Amity University Sector 125 Noida 201313, Uttar Pradesh India
| |
Collapse
|